Party Branch of Pharmaceutical Sales Company Held Democratic Life Meeting
Release time:
2020-07-22
Pharmaceutical Sales Company Party Branch Held Democratic Life Meeting
News 4# July 22 , Jianfeng Pharmaceutical Sales Company Party Branch Held Democratic Life Meeting to Carry out Criticism and Self-criticism.
This meeting is armed with "to strengthen the theory of innovation, build up 'four consciousnesses ' , strengthen ' four self-confidence ' , firmly achieve 'two maintenance ' , and have the courage to act, with the theme of seeking truth and being pragmatic, we will resolutely implement the decision-making and deployment of the Party Central Committee " , connect with the actual work, conduct comparative inspections, analyze party spirit, and carry out criticism and self-criticism. Xu Junxiong, party branch secretary of
Sales Company, summarized the party work of 2018 and took the lead in criticism and self-criticism. He said that to a certain extent, sales companies attach importance to business and neglect party building, and the building of party members also needs to be strengthened. In the future, the sales company will strive to improve these deficiencies according to its own reality, so as to lay a good foundation for the better development of the party branch. Every party member and cadre also made full preparations and actively spoke to point out the shortcomings.
Qin Xuping, member of the Party Committee of the Group Company and Director of the Party and Mass Work Department, and Huang Jinlong, member of the Party Committee of the Group Company, Deputy General Manager, and General Manager of the Pharmaceutical Company, attended the meeting. Qin Xuping said that the party committee of the group company has always attached great importance to democratic life meetings, and enterprises attach importance to production and operation, but party building and enterprise development are a relationship of mutual promotion, symbiosis and common prosperity, and a branch is a fortress. A party member is a banner. Holding a democratic life meeting can exchange ideas, gather strength, play a role, and provide enterprises with strong ideological, political and organizational guarantees.
Golden Dragon also put forward requirements based on the actual situation of the sales company. He hopes that party members and cadres will improve their comprehensiveness through criticism and self-criticism, speak politics and understand politics, and learn to use collective strength and wisdom to promote various tasks. Moreover, sales staff are distributed all over the country. Leading cadres should pay more attention to employees, listen to various voices, innovate ideas, improve management mechanisms, and dare to take responsibility in exploration. (Zhang Zhengbo)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page